For instance, TP53—the most frequently mutated gene in human cancers, often named as—“guardian of the genome” (Chen et al., 2022), turns out to be one of the discriminating tools also in NDD (Chang et al., 2012; Checler and da Alves Costa, 2014; Talebi et al., 2021). Here, TP53 is linked to cancer.